BiomX Inc (PHGE)
0.35
+0.01
(+4.17%)
USD |
NYAM |
Apr 26, 16:00
0.3534
0.00 (0.00%)
After-Hours: 20:00
BiomX Cash from Investing (Quarterly): -0.006M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.006M |
| September 30, 2023 | -0.032M |
| June 30, 2023 | -0.001M |
| March 31, 2023 | 1.99M |
| December 31, 2022 | 1.468M |
| September 30, 2022 | 4.499M |
| June 30, 2022 | 1.946M |
| March 31, 2022 | -10.02M |
| December 31, 2021 | -0.103M |
| September 30, 2021 | -1.311M |
| June 30, 2021 | 12.42M |
| Date | Value |
|---|---|
| March 31, 2021 | 5.168M |
| December 31, 2020 | -9.808M |
| September 30, 2020 | -0.193M |
| June 30, 2020 | -0.527M |
| March 31, 2020 | -0.329M |
| September 30, 2019 | 0.1703M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -70.00M |
| September 30, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-10.02M
Minimum
Mar 2022
12.42M
Maximum
Jun 2021
0.2961M
Average
-0.0035M
Median
Cash from Investing (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 81.67M |
| InspireMD Inc | -0.036M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | 3.919M |
| Raphael Pharmaceutical Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.242M |
| Cash from Financing (Quarterly) | -1.324M |
| Free Cash Flow | -21.34M |
| Free Cash Flow Per Share (Quarterly) | -0.1029 |
| Free Cash Flow Yield | -118.9% |